Navigation Links
An Experimental New Drug Might Be Effective In Treating MS

Studies indicate that ‘Fingolimod’, a new oral drug that is being developed for multiple sclerosis might prove effective.//

The new study has suggests that the experimental drug fingolimod might be effective in helping patients with relapsing multiple sclerosis. It was also reported in the study that if in the larger and detailed studies could show satisfactorily that the patients respond well to the drug, it could offer patients with MS the first effective treatment in the form of a pill.

It was mentioned that fingolimod is one among the several oral MS drugs that are under development. Reportedly around 2 million people suffer from MS, and is one of the leading cause of disease-related neurologic disability among young adults. Only around 30% of the patients claim to get any benefit from the drugs that are currently available. Many patients do not continue the medication due top the many adverse reactions and harsh side effects that they face.

Patricia O'Looney, the director of biomedical research of the National MS Society, states, “There has been a crying need for better therapies for MS. These are exciting preliminary findings for an experimental oral therapy for MS, but larger and longer term studies are needed to determine if this drug lives up to its early promise.”

The pharmaceutical company of Novartis, which manufactures the drug, had also undertaken the cost of the study involving 255 patients. It was explained that the drug fingolimod works by trapping T cells in the lymph nodes thereby keeping them away from the central nervous system where they do their damage.

It was explained that in the study the patients had reportedly received one of the two doses of the drug for up to a year, receiving either a 125 milligrams of an oral dose of the drug or 5 milligrams of the drug or a placebo. Six months later the patients on placebo were switched on to fingolimod, and it was found that among the pat
'"/>




Page: 1 2

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. Experimental drug to fight flu
3. Experimental SARS Vaccine
4. Experimental vaccine for shingles is effective
5. Experimental Blood Test May Spot Heart Attack Risk, Study Says
6. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
7. Protection against HIV and Herpes is possible with the Experimental Microbicide
8. Experimental Therapy Effective Against Malignant Melanoma in Horses
9. Experimental Alzheimer’s Drug curbs the disease in mic
10. New Guidelines to Be Laid While Testing Experimental Drugs
11. Experimental Drug Deals Effectively with Prostate Cancer Cells
Post Your Comments:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...ancer Specialists in Australia have been told that...may be monitored using a mobile phone.// The syste...oms according to their severity, and advice woul...f a red alert sent to medical staff, or an ambulan...
... always the case that women would have to work dou...nterpart, be it in career or otherwise. This was r...as published in “American Journal of Physiology-En...ng to this study, the reason for this is attrribut...
...aced former coal minister Shibu Soren, charged wit...next three days, said a hospital //where he was ad... not well. I do not think that he would be able to... three days," said Shakti Gupta, the medical super...
...n and other Asian men with good or excellent Engli...oblems than those with poorer English //proficienc...S. Asian Americans in general have lower rates of...born Asians and other native-born Americans with E...
Other Medicine News:Health News:Good English Gives Better Mental Health To Asian Americans 2
(Date:8/18/2008)... BOSTON, Aug. 18 /PRNewswire-USNewswire/ -- Bost... President of the Center for Human Genetics, Inc.,...ics of Boston University,announced that CHG will ...s,licensed to Athena Diagnostics, Inc., These pat...aring loss,related to A1555G or Connexin 26 mutati...
(Date:8/18/2008)... Industry Leader with Strong Clinical Research Re...Growth Organizations to Lead Commercialization, S... -- NewCardio, Inc.,(OTC Bulletin Board: NWCI) a ...ounced that Vincent W. Renz has joined NewCardio a...,s commercialization effort, to include,business d...
(Date:8/15/2008)... AUDUBON, Pa., Aug. 15 /- Globus Me...lant manufacturer in the world, today announced,th...been implanted under an,Investigational Device Exe...onald Johnson II and Dr. Rhett Murray., The FLEXU...between two,spinous processes with minimal disrupt...
(Date:8/14/2008)... First T cell engaging antibody (BiTE) showing cli...bles patients own T cells to recognize and attack ...DA, Md., Aug. 14 /- Microme...any developing novel, proprietary,antibodies for t...e,diseases, today announced publication of a Phase...
Breaking Medicine Technology:Vincent W. Renz Joins NewCardio as President 2Vincent W. Renz Joins NewCardio as President 3Vincent W. Renz Joins NewCardio as President 4First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6U S Representatives Gohmert Granger E B Johnson Praised by THCA for Helping Lead House Effort to Stop 2445 6 Million Texas Medicare Cuts 24945 1U S Representatives Gohmert Granger E B Johnson Praised by THCA for Helping Lead House Effort to Stop 2445 6 Million Texas Medicare Cuts 24945 2U S Representatives Gohmert Granger E B Johnson Praised by THCA for Helping Lead House Effort to Stop 2445 6 Million Texas Medicare Cuts 24945 3Regence Introduces Rewards to Activate Members Toward Healthy Living 24941 1Regence Introduces Rewards to Activate Members Toward Healthy Living 24941 2Regence Introduces Rewards to Activate Members Toward Healthy Living 24941 3FDA Reviewing Biomoda Submission for Cancer Screening Study 2772 1FDA Reviewing Biomoda Submission for Cancer Screening Study 2772 2Case Western Reserve University study looks at keeping migrant workers children healthy 4325 1Case Western Reserve University study looks at keeping migrant workers children healthy 4325 2
...wire-FirstCall/ --,Threshold Pharmaceuticals, Inc....g its oncology pipeline, which includes two,precli...rodrug,TH-302, and two research presentations fro...ntations will take place at the 2007,American Asso...being held April 14 - 18, 2007, at the Los Angeles...
...ZIOPHARM Oncology,Inc. (NASDAQ: ZIOP) announced t...rally active form of ZIO-201 (isophosphoramide mus...Research meeting being,held in Los Angeles. Data p... and activity in a variety of cancer models, inclu...mide resistant tumors.,An oral form of IPM, the pr...
Other Medicine Technology:Threshold Pharmaceuticals Announces Multiple Presentations on,Oncology Pipeline at the 2007 American Association for Cancer,Research (AACR) Annual Meeting 2Threshold Pharmaceuticals Announces Multiple Presentations on,Oncology Pipeline at the 2007 American Association for Cancer,Research (AACR) Annual Meeting 3ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR 2ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR 3
...the medication most commonly prescribed for the pr...as heart attacks and strokes. However, a number of...taking daily aspirin therapy to prevent a recurren...ll benefits. These people are at greater risk for...
...p system provides both pressure and flow calculati...creen format utilizing Volcano Therapeutics' high ... FloWire. Physiologic measurements provide the cli...intermediate lesions, confirm stent placement and ...
...e custom-configured for ceiling height, arm reach,...r greater internal capacity accommodates more gas,...e versatile and mobile enough for every surgical p...et with all these capabilities, Teletoms are surpr...
Wampoles MONO-plus test uses direct solid-phase immunoassay technology for the qualitative detection of infectious antibodies in human whole blood, serum or plasma specimens. Our CLIA waived whole bl
Medicine Products: